Sales Growth YoY (Last 12 Months): Sutro Biopharma, Inc. (STRO)

Public company logo of Sutro Biopharma, Inc (STRO)

Sutro Biopharma, Inc. (STRO) revenues rely on partner payments, as the retail market remains inaccessible. The year-over-year revenue change over the trailing twelve months (TTM) clearly demonstrates this process, with the metric standing at -56.70. Sutro Biopharma, Inc. (STRO) is implementing its unique XpressCF protein synthesis to combat cancer, although financial stability currently depends entirely on external funding and clinical trial results.

Sutro Biopharma (STRO) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/17/2026

Sutro Biopharma (STRO) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Sutro Biopharma, Inc.
Product sample of sutrobio.com

The development of ADC drugs and partner advances define the financial profile of Sutro Biopharma, Inc. (STRO). Year-over-year sales dynamics over the last four quarters measure the percentage change in TTM revenue, reflecting the actual pace of business scaling. Growth in this indicator confirms the commercial demand for cell-free protein synthesis. The steady acceleration on the chart signals the viability of the model. Investors use this trend to assess the fundamental value of the asset.

Competitors of Sutro Biopharma, Inc. (STRO)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)